We are proud to share that more than 160 participants have now been enrolled in the ENFORCE study. This research compares focal therapy with the standard treatment for men with prostate cancer.
This milestone brings us closer to our goal of thoroughly and carefully evaluating this treatment strategy, with a focus on both effectiveness and quality of life.
We remain committed to recruiting additional participants so that, together, we can generate reliable and well-founded results.
A sincere thank you to all participants, researchers, and collaborating partners - Radboudumc, Amsterdam UMC, Andros Clinics, Bravis Hospital, HIFU Clinic Netherlands, St. Antonius Hospital, Isala Hospital, the Dutch Prostate Cancer Foundation, Inspire2Live, the Dutch National Health Care Institute, and ZonMw - for their dedication and support.
Together, we are advancing prostate cancer care!
More information about the study can be found here.
